Christoph Kronabel

Former Advisor at EMBL Ventures GmbH

Christoph Kronabel

Christoph Kronabel

Former Advisor at EMBL Ventures GmbH

Biography

Dr. Kronabel was the first member of the HI team in 1997. He is seen as the partner who "keeps the HI clock ticking", taking care of corporate culture and organisational growth. Dr. Kronabel is responsible for transition management within the portfolio and the monitoring of smaller-stake investments.

Dr. Kronabel's academic background is in mathematics, theology and philosophy. He acted as key federal advisor on the restructuring of the medical faculties in Eastern Germany during reunification. Later, Dr. Kronabel built and led the Department for Research, Research Funding and Technology Transfer at the University of Heidelberg.

Dr. Kronabel is currently member of the Investment Committee of EMBL Technology Fund.

Overview
RelSci Relationships

76

Number of Boards

2

Contact Data
Trying to get in touch with Christoph Kronabel? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Christoph Kronabel likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Partner at EMBL Ventures GmbH

Relationship likelihood: Strong

Venture Partner at EMBL Ventures GmbH

Relationship likelihood: Strong

Venture Partner at EMBL Ventures GmbH

Relationship likelihood: Strong

Former Founder & Managing Partner at Heidelberg Innovation Fonds Management GmbH

Relationship likelihood: Average

Chief Executive Officer at invendo medical GmbH

Relationship likelihood: Average

Co-Managing Director at Sorrento Investment GmbH

Relationship likelihood: Average

Chief Executive Officer & Co-Founder at Sloning Bio Technology GmbH

Relationship likelihood: Average

Managing Director at EMBL Ventures GmbH

Relationship likelihood: Average

Chief Executive Officer at Acousia Therapeutics GmbH

Relationship likelihood: Average

Former Chief Financial Officer at Digilab BioVisioN GmbH

Relationship likelihood: Average

Paths to Christoph Kronabel
Potential Connections via
Relationship Science
You
Christoph Kronabel
Former Advisor at EMBL Ventures GmbH
Career History
Advisor
Tenure Unconfirmed

EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties.The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position.EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept.

Managing Director
1997 - 2017

Heidelberg Innovation is a hands-on manager which invests in private German and European (including UK and Scandinavia) companies exclusively in the lifesciences sector, focusing on therapeutics, diagnostics, biochemicals and medical technology.The firm seeks to invest in companies with a competent, experienced management team, an attractive target market, a strategic competitive advantage and timely, attractive exit perspectives. They invest in all stages of company development, with an increasing focus on later-stage development, typically taking minority stakes in their investee companies and partnering with management to support their growth by providing them with in-house expertise and access to their international network.Heidelberg Innovation's exits typically take the form of IPOs and trade sales.

Faculty Member
Prior

A COMMUNITY OF LEARNING THAT PROMOTES AND NURTURES INTELLECTUAL, PERSONAL AND PROFESSIONAL DEVELOPMENT LEADING TO A LIFE OF PURPOSE WITH DISTINCTION.

Boards & Committees
Member, Investment Committee
Current

EMBL Technology Fund GmbH & Co. KG invests in small and start-up companies located in Europe. The fund invests in sectors such as biopharmaceuticals, diagnostics, bioinformatics, medical devices and other breakthrough life science technologies. It provides financing for early stage capital. The fund prefers a role as lead or co-lead investor and also participates in follow-on financing in funding rounds which typically range from €5 million to €30 million. Its total commitment in a single portfolio company can go as high as €8 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christoph Kronabel. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christoph Kronabel's profile does not indicate a business or promotional relationship of any kind between RelSci and Christoph Kronabel.